Navigation Links
Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”
Date:1/14/2014

Rochester, NY (PRWEB) January 14, 2014

During the 1600’s through the 1800’s doctors contributed unknowingly to what is now known as “The Doctor’s Plague.” In this time period, doctors did not know that they needed to wash their hands. This led, at times, to the death of vulnerable patients. In the same way, medical interns and hospital staff today don’t know that they may be unwittingly transmitting herpes viruses to their patients. The CBCD explains.

A study showed that severe fatigue contributed to latent herpes virus reactivation in modern medical interns. The reactivated virus was then transmitted unknowingly to patients as medical interns made their rounds. The study was published on November 9, 2011 in the journal of Interdisciplinary Perspectives on Infectious Diseases (2).

Study authors wrote that “Chronic exposure to complex cognitive and noncognitive stressors (during medical residency) can progress to distress (and) leads to general fatigue (which) has been shown to alter immune responsiveness and (lead to) reactivation of the latent herpes viruses… (2).” In other words, medical interns are exposed to situations that cause extreme fatigue. This fatigue weakens the immune system, which in turn, reactivates the latent herpes virus.

“Physicians, especially those in training, typically work long hours and are often fatigued due to sleep deprivation; fatigue contributes to the human component of medical errors and, thus, jeopardizes patient safety. Decrease in cognitive function was observed among Ob/Gyn residents and medical students … (2).” Moreover, study authors wrote that in these medical interns, “We have detected reactivation of latent herpes viruses that suggests immune suppression (2).”

Reactivation of latent herpes viruses in medical interns places patients at risk. As the study notes, “Fatigue among residents and increased shedding of herpes virus DNA are the major findings of this study. Our subjects have daily close contact with patients in a tertiary care hospital and rotate between intensive care units, operating rooms, the emergency department, inpatient floors, and outpatient clinics. These patients often have a weakened immune system. Increased shedding of viruses by fatigue stressed residents contributes to an unfavorable epidemiological environment (2).”

The CBCD therefore recommends that doctors, medical interns, and hospital administrators learn about Gene-Eden-VIR, a natural product that was tested by scientists at the Center and was proven to reduce symptoms of a herpes infection.

“Control the latent virus and keep it from reactivating can help protect patients. We believe that medical interns and their supervisors owe it to themselves, and to their patients, to become familiar with our research.” – Greg Bennett, CBCD

A clinical study, conducted by scientists at the Center for the Biology of Chronic Disease, and which followed the FDA guidelines for clinical studies, showed that the natural supplement, Gene-Eden-VIR safely and effectively decreases the feeling of fatigue in treated individuals. Specifically, the study found that the natural antiviral product decreased the feeling of general fatigue, the feeling of physical fatigue, and the feeling of mental fatigue (3). The abstract of the study was posted on the Center for the Biology of Chronic Disease website on December 28, 2013 ahead of publication.

To learn more about the CBCD’s research on fatigue, visit http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

References:

(1)    WebMD - Common Symptoms of Genital Herpes. Last Reviewed on December 24, 2013.
http://www.webmd.com/genital-herpes/guide/common-symptoms?page=2

(2) Fatigue in medical residents leads to reactivation of herpes virus latency. Published on November 9, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22229027

(3) Gene-Eden-VIR is Effective Against Fatigue: Results of a Post Marketing Clinical Study Conducted According to the FDA Guidelines. Page last updated on December 27, 2013.
        http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11483359.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Risk of Acquiring Genital Warts in the Mouth from Sex is 50%; polyDNA Recommends Targeting Latent HPV with Gene-Eden-VIR
2. Study: RSV often milder than flu in older adults
3. Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
4. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
5. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
6. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
7. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
8. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
9. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Nature Materials study: Boosting heat transfer with nanoglue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and ... they have entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas ... tools for gene editing across all applications. , Under the terms of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving air ... living in larger cities are affected by air pollution related diseases. , That is ... globally - decided to take action. , “I knew I had to take action ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):